Asthma Canada continues to work toward a future without asthma by contributing to research efforts across the country.
Asthma Canada 2020 Annual Asthma Survey Report: A Snapshot of Asthma in Canada
When Asthma Canada began preparing to launch our 2020 survey, we had no idea what the year would have in store for us. It is safe to say that 2020 is a year unlike any other. The voices of our asthma community — including patients, parents, caregivers and healthcare providers — are especially important during these difficult times, and Asthma Canada continues to meet the changing needs of our community.
A Snapshot of Asthma in Canada: 2019 Annual Asthma Survey Report
Our inaugural annual survey report, A Snapshot of Asthma in Canada, revealed the far-reaching impacts of asthma on the health and everyday lives of Canadians. The report shows that lack of access to medications and proper management are critical issues in the community. Associated conditions like mental health issues are impacting the overall management of asthma. Three high-risk groups were identified: people with low income, those with Severe Asthma, and young adults between 18 and 34 living with asthma, who are disproportionately impacted by the disease.
Severe Asthma: The Canadian Patient Journey
Our study, Severe Asthma: The Canadian Patient Journey revealed the social, financial and health impacts of Severe Asthma on the lives of Canadians. This landmark study is now used to educate, raise awareness and advocate on behalf of the estimated 150,000 – 250,000 Canadians living with Severe Asthma.
Read the report:
Characteristics of Patients with Mild to Severe Asthma in Canada
We support collaboration with community and corporate partners on research that furthers treatment options. In 2016 we worked with Teva Canada in an epidemiological study of the patterns, causes and effects of eosinophilic asthma to better understand the size and scale of the Severe Asthma community. We are proud to have been a part of this study, which leads to a better understanding of eosinophils, a biomarker found in the blood and its relation to asthma, which may lead to the development of more personalized treatments.
Asthma Canada’s National Research Program invests in Canadian asthma research through annual Lead Investigator Awards and Graduate Student Research Grants. By investing in research, we take one step closer to a future without asthma.